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Abstract: In our continuing search for new cytotoxic agents, we assayed extracts, fractions, and pure
compounds from damiana (Turnera diffusa) against multiple myeloma (NCI-H929, U266, and MM1S)
cell lines. After a first liquid-liquid solvent extraction, the ethyl acetate layer of an acetone (70%)
crude extract was identified as the most active fraction. Further separation of the active fraction led to
the isolation of naringenin (1), three apigenin coumaroyl glucosides 2–4, and five flavone aglycones
5–9. Naringenin (1) and apigenin 7-O-(4”-O-p-E-coumaroyl)-glucoside (4) showed significant
cytotoxic effects against the tested myeloma cell lines. Additionally, we established a validated
ultra-high performance liquid chromatography diode array detector (UHPLC-DAD) method for the
quantification of the isolated components in the herb and in traditional preparations of T. diffusa.
Keywords: multiple myeloma; quality control; naringenin; flavonoids; traditional preparation
1. Introduction
Turnera diffusa Willd., Passifloraceae, commonly referred to as damiana, is a shrub occurring
in north-eastern Brazil, Mesoamerica, the Caribbean, Mexico, and Texas [1]. The traditional use of
T. diffusa in Latin America encompasses usage as an aphrodisiac, a tonic, and for the treatment of
diabetes [2,3]. Damiana extracts with tequila are allegedly used as love potions [3]. Due to the long
history of T. diffusa as an aphrodisiac, both the stimulating effect as well as the underlying mechanisms
are relatively well investigated. In animal testing, the aqueous extract of T. diffusa was found to
increase the sexual activity of rats [4]. The flavonoids obtained by percolation with methanol, and here
especially the flavanone pinocembrin, were identified as aromatase inhibitors resulting in increased
testosterone levels and improved libido [5]. Regarding the antidiabetic activity, conflicting results were
obtained. Whereas Alarcon-Aguilar et al. could not find any hypoglycemic effect of an ethanol-water
extract [6], Parra-Naranjo et al. demonstrated hypoglycemic effects of a methanol extract and identified
teuhetenone A, a nor-sesquiterpene, as the active principle [7].
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Apart from traditional usage, an aqueous extract of T. diffusa was found to inhibit the monoamine
oxidase A with IC50 values of 130 mg/mL as well as the acetyl- and butyrylcholinesterase with IC25
values of 0.352 and 0.370 mg/mL, respectively [8]. Additionally, cytotoxic effects of a methanolic
extract against breast carcinoma cell line MDA-MD-231 were demonstrated [9]. Though the mechanism
behind the observed cytotoxicity remains unsolved, the compounds responsible for cell death induced
by the methanolic extract were identified as arbutin and apigenin.
The antioxidative effects of flavonoids are well documented and linked to certain structural
features such as a dihydroxylated B-ring, a double bond located between C2 and C3, and a 4-oxo
function at ring C [10]. Moreover, flavonoids are known to influence the metabolism, e.g., by inhibiting
oxidases or activating antioxidative enzymes [11,12]. However, for flavonoids isolated from T. diffusa
a variety of additional activities were reported. Velutin (7), a dimethoxylated hydroxyflavone
known from the açaí berry (Euterpe oleracea Mart., Arecaceae), has been shown to possess strong
anti-inflammatory effects by inhibiting NF-κB activation as well as p38 and JNK phosphorylation
and hence by down-modulation of the expression of TNF-α and IL-6 [13]. At low doses, velutin (7)
is more potent than established anti-inflammatory agents such as apigenin. Brito et al. found that
the anti-inflammatory effect of velutin (7) against periodontitis is caused by an inhibition of HIF-1α
expression [14]. Besides, the compound was reported to possess cytotoxic effects against human
nasopharynx carcinoma (KB) cells with an IC50 value of 4.8 µM [15]. Acacetin 7-O-methyl ether
(9), another methoxylated flavonoid, showed moderate cytotoxic effects on HeLa cells. Subsequent
testing focused on the influence of aminoalkylation of acacetin 7-O-methyl ether (9) and the resulting
antiproliferative activity against three human cancer cell lines (HeLa, HCC1954, SK-OV-3) [16].
The Mixe Indians (Oaxaca, Mexico) use an aqueous extract of Calea zacatechichi Schltdl. (Asteraceae)
as a remedy for malaria. In subsequent experiments, the flavone genkwanin (6) was identified as
active principle [17]. Boege et al. reported acacetin (5) to inhibit the topoisomerase I [18], though
the compound lacks the structural feature (3-hydroxy group) supposed necessary for topoisomerase
activity [19].
In the present study, the effect of extracts, fractions, and pure compounds from T. diffusa on
multiple myeloma (MM) cell lines was investigated. Flavones, e.g., apigenin, chrysin, and luteolin,
have been shown to block proteasome catalytic activities in tumor cells [20] and to induce cell death
in myeloma cells [21]. Proteasome inhibitors are state-of-the-art in the therapy of multiple myeloma,
but most patients develop resistance over time and new drugs are urgently needed. In addition,
compounds of damiana are expected to induce reactive oxygen species [22], presumably adding to the
expected cytotoxicity in myeloma cells. Our bioactivity-guided approach led to the isolation of seven
flavonoids and a mixture of acacetin and genkwanin (Figure 1, 1–9). In a second step, a validated
ultra-high performance liquid chromatography (UHPLC) diode-array detector (DAD) method for the
quantification of phenolic constituents in extracts and preparations of T. diffusa has been established.
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Figure 1. Chemical structures of flavonoids isolated from the aerial parts of T. diffusa. Naringenin (1), 
apigenin 7-O-(6’’-O-p-E-coumaroyl)-glucoside (2), apigenin 7-O-(6’’-O-p-Z-coumaroyl)-glucoside (3), 
apigenin 7-O-(4’’-O-p-E-coumaroyl)-glucoside (4), acacetin (5), genkwanin (6), velutin (7), 
gonzalitosin I (8), and acacetin 7-O-methyl ether (9). 
2. Results 
2.1. Bioactivity of Tested Fractions 
After an acetone extract (70%) of T. diffusa showed cytotoxic potential in an initial screening 
against MM cell lines (Figure 2a,b (positive control)), the crude extract was fractionated with organic 
solvents of increasing polarity. Subsequently, the obtained fractions TD-1 (ethyl acetate), TD-2 (n-
butanol), TD-3 (acidified n-butanol), and TD-4 (aqueous layer) were evaluated for their cytotoxicity. 
As shown in Figure 2c,d, the cytotoxic activity was mainly retained in the ethyl acetate fraction (TD-
1), resulting in decreased viability in all tested concentrations after both 24 and 48 h of treatment, 
respectively. In contrast, treatment with TD-2 decreased the amount of viable cells only moderately 
after 48 h of treatment, whereas no effects were observed for fractions TD-3 and TD-4.  
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Figure 1. Chemical structures of flavonoids isolated from the aerial parts of T. diffusa. Naringenin (1),
apigenin 7-O-(6”-O-p-E-coumaroyl)-glucoside (2), apigenin 7-O-(6”-O-p-Z-coumaroyl)-glucoside (3),
apigenin 7-O-(4”-O-p-E-coumaroyl)-glucoside (4), acacetin (5), genkwanin (6), velutin (7), gonzalitosin
I (8), and acacetin 7-O-methyl ether (9).
2. Results
2.1. Bioactivity of Tested Fractions
After an acetone extract (70%) of T. diffusa showed cytotoxic potential in an initial screening against
MM cell lines (Figur 2a,b (positive c ntrol)), the crude extract was fraction ted with org ni solve ts
of creasing polarity. S bsequently, the obtained fractions TD-1 (ethyl acetate), TD-2 (n-butanol),
TD-3 (acidified n-butan l), and TD-4 (aqueous layer) wer evaluated for their cytotoxicity. As shown
in Figure 2c,d, the cytotoxic activity was mainly retained in the ethyl acetate fraction (TD-1), resulting
in decreased viability in all tested con entration after both 24 and 48 h of treatment, respectively.
In contrast, treatment with TD-2 decreased the amount of viable cells only mo erately aft r 48 h of
treatment, whereas no effects were observed for f actions TD-3 and TD-4.
olecules 2018, 23, x FOR PEER REVIEW  3 of 15 
 
 
Fig re 1. Che ical structures of flavonoids isolated fro  the aerial parts of T. dif usa. Naringenin (1), 
a igenin 7- -(6’’- -p- -cou aroyl)-glucoside (2), apigenin 7-O-(6’’- -p-Z-cou aroyl)-glucoside (3), 
a i e i  7-O-(4’’-O-p-E-coumaroyl)-glucoside (4), acacetin (5), ge kwanin (6), velutin (7), 
gonzalitosin I (8), and acacetin 7-O-methyl ether (9). 
2. Results 
2.1. Bioactivity of Tested Fractions 
After an acetone extract (70%) of T. diffusa showed cytotoxic potential in an initial screening 
against MM cell lines (Figure 2a,b (positive control)), the crude extract was fractionated with organic 
solvents of increasing polarity. Subsequently, the obtained fractions TD-1 (ethyl acetate), TD-2 (n-
butanol), TD-3 (acidified n-butanol), and TD-4 (aqueous layer) were evaluated for their cytotoxicity. 
As shown in Figure 2c,d, the cytotoxic activity was mainly retained in the ethyl acetate fraction (TD-
1), resulting in decreased viability in all tested concentrations after both 24 and 48 h of treatment, 
respectively. In contrast, treatment with TD-2 decreased the amount of viable cells only moderately 
after 48 h of treatment, whereas no effects were observed for fractions TD-3 and TD-4.  
 
(a) 
 
(b) 
Figure 2. Cont.
Molecules 2019, 24, 855 4 of 15
Molecules 2018, 23, x FOR PEER REVIEW  4 of 15 
 
 
(c) 
 
(d) 
Figure 2. Viability of multiple myeloma (MM) cell lines NCI-H929, U266, and MM1S (a) 48 h after 
treatment with an acetone 70% extract of T. diffusa and after treatment with bortezomib (b). Viability 
of NCI-H929 cells 24 and 48 h after treatment with ethyl acetate (TD-1), n-butanol (TD-2), acidified n-
butanol (TD-3) fractions and the remaining water layer (TD-4) derived from an acetone (70%) extract 
of T. diffusa (c and d). Three concentration levels (25, 50, 100 µg/mL) are shown. 
In a second approach, the crude acetone extract was fractionated in smaller polarity steps using 
n-hexane (TD-1a), diethyl ether (TD-1b), and ethyl acetate (TD-1c). The resulting fractions as well as 
TD-1 were then evaluated for their cytotoxic potential against MM cell lines MM1S, U266, and NCI-
H929 after 24 h of incubation (Figure 3). As expected, TD-1 decreased viable cells significantly at a 
concentration of 100 µg/mL, but not at lower concentrations. Unlike before, partitioning in smaller 
polarity steps did not result in a single active fraction but revealed different activities for TD-1a to 
TD-1c. At a concentration of 100 µg/mL, TD-1a and TD-1b showed pronounced effects against MM1S 
cell lines, which were higher in TD-1b and lower in TD-1a, compared to TD-1. TD-1b moreover 
showed higher activity against NCI-H929 cell lines than TD-1 and slightly stronger effects against 
U266 cell lines. In contrast, TD-1a was less active against these two cell lines. TD-1c was only 
moderately active against all three tested cell lines. 
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Three concentration levels (25, 50, 100 µg/mL) and 24 h incubation times are shown. 
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and NCI-H929 after 24 h of incubation (Figure 3). As xpected, TD-1 d creased viab e cells s gnifican ly
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2.2. Chromatographic Analyses of Tested Fractions
The tested fractions were analyzed by UHPLC in order to eventually attribute the observed effects
to specific peaks (Figure 4). Comparison of fractions TD-1 and TD-2, which were obtained in the first
separation step, clearly shows that the active fraction TD-1 contains a number of peaks that are missing
in fraction TD-2. These peaks, which are eluting after 25 min comprise, amongst other, the later isolated
compounds 2, 3 and 5–9. UHPLC analysis of the three fractions of the second partitioning step (TD-1a
to TD-1c) resulted in similar findings. Here, fraction TD-1c, which was significantly less active than
TD-1a and TD-1b, was lacking compounds 5–7 and showed clearly lower amounts of compounds 8
and 9. However, compound 4 was present in more or less the same concentration and compounds 2, 3
and various polar constituents were present in higher amounts. The difference between fraction TD-1a
and the slightly more active fraction TD-1b was less significant. Apart from the presence of a few peaks
in the more polar region, TD-1b showed higher amounts of compounds 5–8 and lower concentrations
of compounds 2 and 9. Thus, the isolation of peaks eluting after 25 min was considered most promising
for the identification of the cytotoxic principle(s) present in T. diffusa. As the respective compounds
were quantitatively extracted in the first separation step, but not in the second one, fraction TD-1 was
chosen for isolation of the desired substances.
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2.3. Isolation of Natural Compounds
Separation of fraction TD-1 was accomplished by silica gel flash chromatography, Sephadex
LH-20 gel permeation chromatography, as well as preparative medium- and semi-preparative
high-performance liquid chromatography and yielded seven flavonoids and a mixture of two
compounds. Using analytical reference standards, mass spectrometry (MS) and nuclear magnetic
resonance (NMR) spectroscopy, the isolated compounds were identified as naringenin (1), apigenin
7-O-(6”-O-p-E-coumaroyl)-glucoside (2), apigenin 7-O-(6”-O-p-Z-coumaroyl)-glucoside (3), apigenin
7-O-(4”-O-p-E-coumaroyl)-glucoside (4), acacetin (5), genkwanin (6), velutin (7), gonzalitosin I (8),
and acacetin 7-O-methyl ether (9).
2.4. Bioactivity of Isolated Compounds
Cytotoxic assays of the pure compounds resulted in the identification of two compounds (1 and 4)
with significant impact on cell viability (Figure 5). Of these two compounds, naringenin (1) was found
cytotoxic even at low concentrations, showing a decreased viability of NCI-H929 and U266 cell lines of
25.5 ± 12.5 and 79.6 ± 15.2%, respectively, after 24 h incubation time. At the same incubation time and
at a concentration of 50 µM, compound 4 decreased the viability of the same cell lines (NCI-H929 and
U266) to 66.1 ± 17.4 and 84.4 ± 3.7%, respectively. Peripheral blood mononuclear cells (PBMC) from
healthy donor (HD) were affected by the treatment with compounds 1 and 4, if however, in different
extent than the cancer cell lines.
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2.5. Validation of UHPLC-DAD Assay
Of the isolated flavonoids, compounds 4 to 8 were chosen as calibration standards, using
compound 4 to co-quantify compounds 2 and 3 and compound 8 to co-quantify compound 9.
Linearity was achieved by five-point calibration with a coefficient of determination of >0.99 (Table 1).
Repeatability and precision measurements were performed using a dimethyl sulfoxide (DMSO) extract
(Figure 6). Repeatability experiments revealed relative standard deviations (RSD) below 2.3% (Table 2).
Intra-day precision showed RSD values below 6.9% for all compounds on day 1. The relative standard
deviation on day 2 showed similar results for most compounds except for compounds 5–7, which had
higher deviations. Also, inter-day precision was higher for these compounds, with values of 6.9 and
7.8%, whereas the other compounds showed RSD values below 6%. Spiking experiments over four
calibration levels conducted for compounds 4 to 8 showed recovery rates ranging from 98.0 to 127%
(Table 3).
Table 1. Regression curves, coefficients of determination, limit of detection (LOD), and limit of
quantitation (LOQ) of the UHPLC method.
Compound Regression Curve R2 LOD 1 LOQ 1
4 6.971× 109 × (−3.027× 105) 0.9985 1.39 4.60
5 + 6 8.170× 109 × (−1.455× 106) 0.9955 0.162 0.535
7 3.605× 109 × (−5.394× 105) 0.9956 0.236 0.780
8 9.720× 109 × (−1.862× 106) 0.9924 0.120 0.396
1 Concentrations are given in µg/mL.
Table 2. Repeatability and precision of the UHPLC method.
Compound Repeatability 1 Intra-day 1 1 Intra-day 2 1 Inter-day 1
2 12.9 (0.138) 10.9 (4.95) 10.6 (4.90) 10.8 (4.82)
3 2.16 (2.29) 1.73 (5.52) 1.68 (4.20) 1.71 (4.97)
4 8.38 (1.19) 7.73 (4.18) 7.29 (4.83) 7.51 (5.25)
5 + 6 1.96 (1.62) 1.72 (3.02) 1.55 (5.48) 1.64 (6.89)
7 2.12 (1.05) 1.63 (6.89) 1.71 (9.01) 1.67 (7.82)
8 1.08 (0.389) 0.907 (3.37) 0.897 (3.66) 0.902 (3.40)
9 1.73 (0.169) 1.39 (4.87) 1.39 (5.34) 1.39 (4.88)
1 Concentrations are given in µg/mL, relative standard deviations are given in parentheses and are stated in percent.
Table 3. Accuracy of the UHPLC method.
Compound Sample Concentration 1 Spiked Amount 2 Total Concentration 1 Recovery 3
4 6.56
3.08 4.72 105
7.69 12.6 113
15.4 18.7 112
23.1 24.7 111
5 + 6 1.38
0.401 0.746 102
1.07 2.10 99.7
2.14 2.83 106
3.21 3.55 107
7 1.52
0.585 0.964 102
1.04 2.18 100
2.08 2.84 102
3.12 3.50 99.2
8 0.798
0.297 0.497 109
0.793 1.39 109
1.59 1.99 109
2.09 2.29 127
1 Concentrations are given in µg/mL. 2 Amounts are given in µg. 3 Recovery is stated in percent.
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Figure 6. Chromatogram of a dimethyl sulfoxide (DMSO) extract prepared from T. diffusa. UHPLC was
performed using a solvent mixture of 0.1% formic acid in water (solvent A) and acetonitrile (solvent B)
with the following gradient: 15% B to 25% B in 15 min, to 29% B in 9 min, to 29% B in 11 min, to 36%
B in 1 min, to 36% B in 19 min, to 95% B in 0.1 min, to 95% B in 9.9 min. Post-run was set to 10 min,
temperature to 32 ◦C. The injection volume was 5 µL. The UV trace was recorded at 330 nm. The flow
was 0.2 mL/min.
2.6. Chromatographic Analyses of a Tradit onal Preparation
The established ethod as t analysis of a traditional preparation of
T. diffusa (Figure 7). The sample of a tra iti l . iff sa revealed minor compounds in
the medium to low polarity range and a high content of polar compounds. By comparison with MS
data and retention times of isolated compounds from T. diffusa compounds 4 to 9 were identified and
their yield quantified using the method described above. Ultraviolet (UV) spectroscopy experiments
indicated the presence of phenolic compounds in the polar range. Apigenin (e) was identified using
reference standards. Previo s investi ti f a e e tr t f . dif usa by Bernardo et al.
revealed a variety of apigenin, luteolin, and quercetin glycosides [8]. By comparison with ultraviolet
(UV) and MS data larycitrin-3-O-(6-glucosyl)glucoside (a), apigenin 8-C-(2-rhamnosyl)glucoside (b),
(luteolin 8-C-(2-rhamnosyl)ketodeoxihexoside (c), apigenin 7-O-(2-rhamnosyl)ketodeoxihexoside (d)
were detected.
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Figure 7. Chromatogram of a liquor prepared from T. diffusa. UHPLC was performed using a solvent
mixture of 0.1% formic acid in water (solvent A) and acetonitrile (solvent B) with the following gradient:
15% B to 25% B in 15 min, to 29% B in 9 min, to 29% B in 11 min, to 36% B in 1 min, to 36% B in
19 min, to 95% B in 0.1 min, to 95% B in 9.9 min. Post-run was set to 10 min, temperature to 32 ◦C.
The injection volume was 5 µL. The ultraviolet (UV) trace was recorded at 330 nm. The flow was 0.2
mL/min. 4 to 9 refer to the isolated compounds (see Figure 1), compounds a to d were identified
by UV spectroscopy and MS spectrometry experiments as larycitrin-3-O-(6-glucosyl)glucoside (a),
apigenin 8-C-(2-rhamnosyl)glucoside (b), (luteolin 8-C-(2-rhamnosyl)ketodeoxihexoside (c), apigenin
7-O-(2-rhamnosyl)ketodeoxihexoside (d), and e was identified as apigenin by an authentic standard.
3. Discussion
3.1. Bioactivity of Tested Fractions
A crude acetone (70%) extract of T. diffusa displayed promising cytotoxicity against MM cell
lines. Partitioning of the acetone extract located the cytotoxic compounds in the ethyl acetate (TD-1)
fraction. In a second approach, using smaller polarity steps, the activity was found in the n-hexane
(TD-1a) and the diethyl ether (TD-1b) fraction, while the remaining ethyl acetate fraction (TD-1c)
was only slightly active. UHPLC experiments of the active fractions revealed similar peak patterns
in the low polarity range. This peak pattern was absent in the inactive fraction TD-2, and different
in TD-1c. Thus, further purification steps with fraction TD-1 focused on this polarity range and
afforded the isolation of naringenin (1), apigenin 7-O-(6”-O-p-E-coumaroyl)-glucoside (2), apigenin
7-O-(6”-O-p-Z-coumaroyl)-glucoside (3), apigenin 7-O-(4”-O-p-E-coumaroyl)-glucoside (4), acacetin
(5), genkwanin (6), velutin (7), gonzalitosin I (8), and acacetin 7-O-methyl ether (9).
Regarding the isolated compounds, compound 4 was abundant in all active fractions (TD-1, TD-1a
to TD-1c) but was absent in TD-2. Treatment with compound 4 (50, 100 µM) led to decreased viability
of NCI-H929 and in a lesser extent of U266 after incubation for 24 h. This indicates that compound
4 contributes to the cytotoxic effect observed for the tested fractions. The corresponding aglycone,
the flavone apigenin, was reported repeatedly for its cytotoxic activity [9,20,21,23,24]. However,
the moderately active fraction TD-1c contained less of lipophilic compounds 5 to 9, suggesting that
these compounds might at least contribute to the observed cytotoxic effects.
The most active co pound of our study, the flavanone naringenin (1), is well investigated
for its ability to induce apoptosis against HL-60 cells via the activation of caspase-3, a member of
Molecules 2019, 24, 855 10 of 15
the caspase-cascade that plays an important role in apoptosis. Interestingly, the cytotoxic effect of
naringenin (1) was found to be weakened if C7 is substituted with a sugar moiety (rutinoside) [25,26].
In the present work, naringenin (1) was found to possess the highest activity of all tested substances
and showed a pronounced decrease of viability especially in NCI-H929 cells. Nevertheless, the active
principle resulting in the lowered viability in this study requires further testing.
The experiments performed under the same conditions with HD cells indicate a negative influence
on cells of the immune system after treatment with compound 1 or 4 (Figure 5). Interestingly, Chen et al.
(2003) did not observe apoptosis in polymorphonuclear neutrophils (PMN) after their treatment with
naringenin (1). However, testing conditions differed from the ones used in this study. Nevertheless,
though flavonoids are generally assumed safe due to regular uptake with fruits and vegetables,
they were found to evoke cytotoxic effects at higher doses [27,28].
3.2. Validation
By testing different columns (Synergi 4µm Polar-RP 80 Å 150× 2.00 mm, Luna Omega 1.6 µm C18
100 Å 100 × 2.1 mm, Kinetex 1.7 µm XB-C18 100 Å 100 × 2.1 mm) the best separation was achieved for
the C18 Luna Omega column. Consequently, it was chosen as starting point for method development.
Different compositions of pure water or formic acid in water as well as methanol or acetonitrile
were tested for their influence on the separation of the compounds of the DMSO extract. Thereby,
0.1% formic acid and acetonitrile were identified as suitable eluents and a column temperature of
32 ◦C was found to give a good resolution of the peaks. Due to the complex mixture and a variety
of similar compounds within the crude extract, isocratic steps were performed at different solvent
concentrations as part of the gradient. Because of the absorption maxima around 330 nm of compounds
4 to 8, this wavelength was chosen for detection. An injection volume of 5 µL was found to provide a
good repeatability with an acceptable peak resolution.
The calibration curves for quantified constituents 4 to 8 were obtained on five levels each regarding
the concentration of the corresponding analyte in the extract. The established calibration curves had
determination coefficients of more than 0.99 and were thus accepted for quantification purposes.
Spiking experiments showed acceptable recovery rates over a broad calibration range (Table 3).
Interday precision revealed good relative standard deviation (RSD) values for peaks 5 to 8;
compound 7 however varies in a bigger extent. These findings also account for the co-quantified peaks
with acacetin 7-O-methylether (9) and the compounds 2 and 3 having similar deviations. Displaying
structural isomers, the latter two compounds were co-quantified by compound 4, while acacetin and
genkwanin (5 + 6) were chosen to co-quantify acacetin 7-O-methylether (9) since the molecules only
differ in the amount of one methyl group.
Limit of quantification (LOQ) for all quantified compounds 4–8 was set to the lower limit of the
calibration curve. Those values provide acceptable standard deviation (data not shown). Commonly,
limit of detection (LOD) is defined as one third of LOQ. Therefore, LOD was calculated from the LOQ
(Table 2).
3.3. Traditional Preparation
T. diffusa is used as remedy for various diseases in the traditional medicine of Latin America.
Additionally, a liquor of T. diffusa is used to increase sexual activity [3]. In literature, tequila is described
as extraction agent while in this study Kornbrand (Bauerndank/Edeka/Hamburg, Germany) was used.
Both liquors contain 38% ethanol and thus were considered comparable. Due to the contained water,
the liquor was expected to contain a high number of polar compounds. This assumption was verified
by UHPLC analysis, which revealed most of the peaks eluting in the polar range. Compounds 4 to 9
were present, however, at low concentrations. In the present study, compound 4 showed moderate
cytotoxicity in an in vitro assay against myeloma cell lines and healthy donor (HD) cells at higher
concentrations of 50 and 100 µM. This corresponds with 28.9 mg/mL or 57.8 mg/mL, a concentration
unlikely to be met in traditional preparations.
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4. Materials and Methods
4.1. General Experimental Procedures
Solvents and reagents for isolation were of analytical quality. Solvents used for UHPLC
were of LC-MS grade quality. Column chromatography was performed with silica gel (40–63 µm
particle size) (Merck, Darmstadt, Germany) or with Sephadex LH-20 (GE Healthcare, Chicago, IL,
USA). Thin layer chromatography (TLC) was performed on silica gel 60 F254 plates (Merck) using
ethyl acetate-methanol-water (10:1:1) or n-hexane-ethyl acetate-methanol-formic acid (7:4:1.5:0.1) as
mobile phase and vanillin-sulphuric acid for detection. Preparative medium-performance liquid
chromatography (MPLC) was accomplished using a Büchi PrepChrom C-700 equipped with a Büchi
PrepChrom MPLC column C18 (250 × 30 mm, 15 µm) (Büchi, Flawil, Switzerland). Semi-preparative
high-performance liquid chromatography (HPLC) was carried out on Waters a Alliance e2695
Separations Module with Alliance 2998 photodiode array (PDA), 2410 RI, and WFC III fraction
collector (Waters, Milford, MA, USA), and either an Aqua 5 µ C18 column (250 × 10 mm, 5 µm particle
size, Phenomenex, Aschaffenburg, Germany) or a VP Nucleodur C18 (250 × 10 mm, 5 µm particle
size, Macherey-Nagel, Düren, Germany). Extracts, fractions, and pure compounds were analyzed
by a Hitachi ChromasterUltra RS System (VWR, Darmstadt, Germany) connected to an autosampler,
column heater, PDA and a Sederé Sedex 100 evaporative light scattering detector (ELSD), using a
Phenomenex Synergi Polar-RP column (150 × 2 mm, 4 µm particle size). Pure compounds were
additionally analyzed by Nexera X2 system (Shimadzu, Kyoto, Japan) connected to an autosampler,
column heater, PDA and a Shimadzu LCMS 8030 Triple Quadrupole Mass Spectrometer with electron
spray ionization. Quantification was performed on the same instrument using a Phenomenex Luna
Omega C18 column (100 × 2.1 mm, 1.6 µm particle size) and NMR spectra were recorded on an
Avance III 300 NMR spectrometer (Bruker, Billerica, MA, USA) connected to a BACs-autosampler
(Bruker). Centrifugation was performed on a Heraeus Megafuge 16 (Thermo Fisher Scientific Inc.,
Waltham, MA, USA). The authentic standard of Apigenin >98% HPLC was purchased from TransMIT
(Gießen, Germany).
4.2. Plant Material
Dried and cut aerial parts of T. diffusa (HAB-2014 quality) were obtained from Caesar & Loretz
GmbH (Caelo), Hilden, Germany (art.-No.: 257a, lot number: 15294206).
4.3. Extraction and Fractionation
Dried herb (1.00 kg) was ground and extracted five times with 2 liters of acetone 70% undergoing
sonification. The solvent was evaporated under reduced pressure to afford 85 g of crude extract.
For isolation the crude extract was repeatedly partitioned between ethyl acetate and water and the
ethyl acetate layer was evaporated to dryness, yielding 32.6 g (TD-1). Subsequently, this procedure
was repeated with butanol (14.6 g, TD-2). After acidification of the water layer with 2.5 mL formic
acid, the solution was again extracted with butanol (5.40 g, TD-3) and the aqueous layer was then
evaporated to dryness, yielding 32.4 g (TD-4).
In a second approach, 5.0 g of crude extract were suspended in water and extracted with n-hexane.
The fraction was evaporated to dryness, yielding 0.53 g (TD-1a). The procedure was repeated with
diethyl ether (0.21 g, TD-1b) and ethyl acetate (0.22 g, TD-1c).
For the validated UHPLC-DAD assay, sieved plant material (800 µm mesh width) was extracted
threefold with DMSO, centrifuged, and the supernatants were collected and diluted in a 20 mL
volumetric flask.
The traditional liquor from T. diffusa was prepared by maceration of 35 g of ground drug material
with 0.7 liters of 38% alcohol (Bauerndank) for four weeks. Subsequently, the extract was filtered.
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4.4. Isolation
TD-1 was subjected to silica gel column chromatography (40 × 8 cm) and eluted in a gradient
manner with petroleum ether-ethyl acetate-methanol-water (10:0:0:0 to 0:0:19:10) yielding 160 fractions.
After characterization by TLC the obtained subfractions were combined to 20 fractions (TD-1_1 to
TD-1_20).
From TD-1_2 compound 1, a two to one mixture of 5 and 6, and compound 8 were obtained after
column chromatography with Sephadex LH20 and acetone–dichloromethane (15:85) as eluting solvent.
The thereby eluted subfraction TD-1_2_D was subjected to semi-preparative HPLC using 0.025%
formic acid in water and methanol in a gradient matter, yielding 14.2 mg of velutin (7) and 27.8 mg of
linoleic acid. 27 mg of acacetin 7-O-methylether (9) and another 58 mg of linoleic acid were obtained
from TD-1_4 by preparative column chromatography using 0.025% formic acid in water and methanol
in a gradient matter. TD-1_8 (196 mg) was submitted to further separation by Sephadex LH20 (using
acetone as eluent) to give 11.7 mg of compound 4. TD-1_12 was subjected to semi-preparative HPLC
using 0.025% formic acid in water and acetonitrile in an isocratic matter, yielding 6.3 mg of compound
3. TD-1_14 yielded 10.0 mg of sitosterol and TD-1_ 20 9.0 mg of compound 2. Structure elucidation of
the isolated compounds was accomplished by comparison of MS- and NMR-spectra with literature
data [29–36]. MS and NMR spectra (1H, HSQC, HMBC) are provided in the Supplementary Materials
(S1 to S15).
4.5. Cytotoxic Assays
Cytotoxicity was assessed for TD-1 to TD-4, TD-1a to TD-1c as well as compounds 1 and 3 to
9. Induction of apoptosis was measured in myeloma cell lines NCI-H929, MM1S, and U266 as well
as in PBMCs of healthy donors by flow cytometry using established protocols [37] thereby staining
the cells with Annexin-fluorescein isothiocyanate and propidium iodide. Bortezomib (Eubio, Vienna,
Austria) was used as positive control. Cell lines were purchased from DSMZ (Braunschweig, Germany)
and routinely fingerprinted and tested for mycoplasma negativity. All cells (cell lines and PBMC)
were grown in RPMI-1640 medium (Life Technologies, Paisley, UK) supplemented with 10% fetal
calf serum (FCS; PAA, Linz, Austria), L-glutamine 100 µg/ml, and penicillin-streptomycin 100 U/ml.
PBMCs from healthy donors were utilized after obtaining written informed consent at the University
Hospital Salzburg (ethics committee approval 415-E/1287/6-2011). Cells were subjected to Ficoll
separation (Ficoll PaqueTM, VWR, Darmstadt, Germany), and incubated in RPMI-1640 Media with
supplements as above. In brief, 0.5 × 106 myeloma cells/mL or similar numbers of PMBCs were
incubated for 24 h and 48 h with or without the tested compounds dissolved in DMSO in different
concentrations. At least three analysis in triplicates were performed for each cell line and a solvent
control was included. The extent of non-apoptotic cells (AnnexinV/propidium iodide negative) was
calculated as percentage of viable cells in respect to the untreated control. Data are shown as mean
percentage of viable cells and standard deviation (error bars).
4.6. Chromatographic Analyses
Solvents used for UHPLC analyses during isolation steps were 0.1% formic acid in water and
methanol using a gradient from 40% of methanol to 95% in 80 min with a flow of 0.2 mL/min. Post-run
was 10 min, injection volume 5 µL, temperature 30 ◦C. UV traces were detected at 210 nm, 254 nm,
and 280 nm. Additionally, an evaporative light scattering signal was recorded.
For quantification a solvent mixture of 0.1% formic acid in water (solvent A) and acetonitrile
(solvent B) was used with the following gradient: 15% B to 25% B in 15 min, to 29% B in 9 min, to 29%
B in 11 min, to 36% B in 1 min, to 36% B in 19 min, to 95% B in 0.1 min, to 95% B in 9.9 min. Post-run
was set to 10 min, temperature to 32 ◦C. The injection volume was 5 µL. The UV trace was recorded by
at 330 nm. The flow was 0.2 mL/min.
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4.7. Method Validation
The UHPLC-DAD method was validated for linearity, LOD and LOQ, accuracy, precision,
and repeatability. For the determination of linearity calibration curves were established by serial
dilution of compounds 4 to 8. Thus, calibration ranges of 5 µg/mL to 50 µg/mL (4), 0.75 µg/mL to
7.5 µg/mL (7), and 0.5 µg/mL to 5 µg/mL (5 + 6 and 8) were obtained. Corresponding regressions
curves, coefficients of determination as well as LOD and LOQ are given in Table 1.
Repeatability was determined by measuring one sample six-fold while intra-day precision was
studied by measuring six different samples once. Interday precision of the method was verified by
assessing six samples on two different days. Consistency of compound concentrations was thereby
investigated (Table 2).
Spiking experiments were performed on four levels for each quantified compound. For compound
5 + 6, 7, and 8 stock solutions of 0.04 mg/mL were prepared. From these, 0.75 mL, 0.5 mL or 0.25 mL
were taken and mixed with 0.25 mL, 0.5 mL or 0.75 mL of the plant extract. Additionally, for all
quantified constituents 0.25 mL of the lowest level of the calibration curve was added to 0.75 mL of the
extract. Of these resulting solutions 5 µL were injected three-fold. Results are given in Table 3.
Acacetin 7-O-methylether (9) was co-quantified by acacetin and genkwanin (5 + 6), compounds 2
and 3 by compound 4.
5. Conclusions
Investigation of the cytotoxic properties of T. diffusa revealed significant effects for different
apolar extracts against the myeloma cell lines MM1S, U266 and NCI-H929. Systematic evaluation
of the active extracts by UHPLC led to the reduction of the complex metabolite to a range of
possible candidates, which were subsequently isolated. Of these compounds, naringenin (1) and
apigenin 7-O-(4”-O-p-E-coumaroyl)-glucoside (4) were identified as two components responsible for
the observed activity. The cytotoxicity of naringenin is in line with previous findings, if however,
observed for other cell lines [25,26]. Up to the best of our knowledge, compound 4 is described as
cytotoxic for the first time. Nevertheless, its aglycone apigenin has been found active against cancer
cell lines before [9,20,21,23,24]. Interestingly, only one of the two tested apigenin coumaroyl glucosides
(compounds 3 and 4) showed activity in the conducted assays, indicating steric effects to play a pivotal
role for the cytotoxicity of these compounds.
Furthermore, the present study describes the first validated UHPLC-DAD method for the
quantification of phenolic constituents in T. diffusa. The established assay allows the quantitation
of eight flavonoids in both, the herb and the traditional preparation of T. diffusa, and coupled to
mass spectrometry gives information on the abundance of another five flavonoids occurring in
hydroethanolic damiana extracts.
Supplementary Materials: The following are available online, Figures S1–S15.
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